Alector (ALEC) Asset Utilization Ratio (2019 - 2026)

Alector (ALEC) reported Asset Utilization Ratio of 0.07 for Q1 2026, down 65.72% year-over-year from 0.2 in Q1 2025, and up 3.17% quarter-over-quarter from 0.07 in Q4 2025.

Alector (ALEC) Asset Utilization Ratio (2019 - 2026) Analysis & Trends

Alector (ALEC) has 8 years of Asset Utilization Ratio data on file, last reported at 0.07 in Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.07, down 65.72% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.07 (down 65.72% YoY), and the FY2025 annual result was 0.06, down 70.04% from the prior year.
  • Asset Utilization Ratio climbed to 0.07 in Q1 2026 per ALEC's latest filing, from 0.07 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.33 in Q2 2022 and troughed at 0.07 in Q4 2025.
  • A 5-year average of 0.17 and a median of 0.15 in 2022 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio surged 561.91% in 2022, then sank 67.22% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.16 in 2022, then retreated by 8.81% to 0.15 in 2023, then surged by 36.22% to 0.2 in 2024, then slumped by 67.22% to 0.07 in 2025, then climbed by 3.17% to 0.07 in 2026.
  • Business Quant data shows ALEC's Asset Utilization Ratio at 0.07 in Q1 2026, 0.07 in Q4 2025, and 0.2 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Alector 193.53 Mn -12.98 Mn - 0.07

Historic Data

Download Data
DateValue
Mar 31, 2026 0.07
Dec 31, 2025 0.07
Sep 30, 2025 0.20
Jun 30, 2025 0.21
Mar 31, 2025 0.20
Dec 31, 2024 0.20
Sep 30, 2024 0.11
Jun 30, 2024 0.09
Mar 31, 2024 0.15
Dec 31, 2023 0.15
Sep 30, 2023 0.14
Jun 30, 2023 0.14
Mar 31, 2023 0.16
Dec 31, 2022 0.16
Sep 30, 2022 0.15
Jun 30, 2022 0.33
Mar 31, 2022 0.26
Dec 31, 2021 0.25
Sep 30, 2021 0.32
Jun 30, 2021 0.05